Article

Carolyn Presley on the Implications of Screening on Lung Cancer Care

Author(s):

Carolyn Presley

Carolyn Presley discusses the implications of screening on diagnosis and treatment of lung cancer.

Carolyn Presley, clinical fellow, geriatric oncology, Yale Cancer Center, Robert Wood Johnson Clinical Scholar, discusses the implications of screening on diagnosis and treatment of lung cancer.

Read more about the study.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Dr. Rosario Ligresti
Image of women with text.
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.
Related Content
image of Sue mccarthy.
August 23rd 2025

A Close Companion Throughout my Cancer Journey

Sue McCarthy
CURE Cancer Horizons logo
August 23rd 2025

FDA Approvals from February 2024

Alex Biese Brielle Benyon
Sue McCarthy received diagnoses of breast cancer in 2001 and lung cancer in 2018. Catch up on all of Sue's blogs here!
August 23rd 2025

Reuniting a Family After Multiple Cancer Diagnoses

Sue McCarthy
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
August 23rd 2025

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Image of man with text.
August 23rd 2025

The Variability of Data and Importance of Personalized Lung Cancer Care

Ryan Scott
Image of lungs.
August 23rd 2025

FDA Approves Companion Diagnostic Test for Hernexeos in NSCLC

Ryan Scott